tradingkey.logo
tradingkey.logo
Search

Phio Pharmaceuticals Corp

PHIO
Add to Watchlist
1.040USD
0.0000.00%
Close 07-27 16:00ETQuotes delayed by 15 min
12.08MMarket Cap
LossP/E TTM

PHIO Financials

See Phio Pharmaceuticals Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Phio Pharmaceuticals Corp Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.34/-0.24
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.45
83.99%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
16.10%-0.34
82.28%-0.25
71.58%-0.44
98.61%-0.45
90.30%-0.41
74.77%-1.43
84.99%-1.54
-145.36%-32.56
85.09%-4.23
73.73%-5.67
---10.25
---13.27
---28.38
---21.58
---69.33
----
----
----
----
----
Net Profit
-126.29%-4.00M
-45.82%-2.37M
-56.96%-2.39M
-17.33%-2.17M
17.87%-1.77M
14.20%-1.63M
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
30.61%-1.90M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.60M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
22.45%-2.64M
-40.17%-3.45M
-62.06%-3.74M
-60.71%-2.69M
Operating profit
-122.60%-4.17M
-51.37%-2.53M
-57.55%-2.50M
-20.64%-2.31M
15.26%-1.87M
5.58%-1.67M
42.72%-1.59M
24.85%-1.91M
38.67%-2.21M
35.05%-1.77M
22.26%-2.78M
-1.03%-2.55M
-36.44%-3.60M
20.87%-2.73M
4.49%-3.57M
6.07%-2.52M
27.43%-2.64M
-40.13%-3.45M
-62.14%-3.74M
-60.81%-2.68M
Net Profit
-126.29%-4.00M
-45.82%-2.37M
-56.96%-2.39M
-17.33%-2.17M
17.87%-1.77M
14.20%-1.63M
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
30.61%-1.90M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.60M
20.86%-2.73M
4.44%-3.58M
5.81%-2.53M
22.45%-2.64M
-40.17%-3.45M
-62.06%-3.74M
-60.71%-2.69M
Current assets
29.52%17.40M
274.41%21.48M
95.99%11.49M
113.42%11.29M
96.20%13.44M
-38.47%5.74M
-37.14%5.86M
-56.03%5.29M
-27.18%6.85M
-25.10%9.32M
-39.34%9.33M
-38.87%12.04M
-56.60%9.40M
-49.67%12.45M
-43.98%15.38M
-36.81%19.69M
-34.98%21.67M
63.06%24.73M
55.79%27.45M
59.33%31.16M
Total current liabilities
-25.20%950.00K
32.02%1.34M
81.28%1.67M
-20.81%1.21M
1.68%1.27M
-37.88%1.01M
-60.49%919.00K
-36.33%1.52M
-47.87%1.25M
-15.73%1.63M
6.02%2.33M
-21.24%2.39M
-6.88%2.40M
-36.80%1.94M
-12.06%2.19M
17.80%3.04M
17.43%2.57M
39.71%3.07M
11.88%2.50M
36.19%2.58M
Total assets
29.55%17.41M
274.47%21.49M
96.16%11.51M
113.39%11.30M
96.12%13.44M
-38.72%5.74M
-38.52%5.87M
-56.93%5.30M
-29.40%6.85M
-26.92%9.36M
-39.59%9.54M
-38.96%12.30M
-56.20%9.71M
-49.09%12.81M
-43.49%15.79M
-36.37%20.14M
-34.54%22.16M
59.92%25.17M
53.20%27.94M
56.63%31.66M
Total liabilities
-25.20%950.00K
32.02%1.34M
81.28%1.67M
-20.81%1.21M
1.68%1.27M
-37.88%1.01M
-60.49%919.00K
-36.33%1.52M
-47.87%1.25M
-17.22%1.63M
2.74%2.33M
-23.85%2.39M
-11.62%2.40M
-39.04%1.97M
-16.05%2.26M
11.70%3.14M
10.38%2.71M
18.96%3.24M
-3.19%2.70M
13.48%2.81M
Total equity
35.27%16.46M
326.57%20.15M
98.93%9.84M
167.56%10.10M
117.17%12.17M
-38.90%4.72M
-31.43%4.95M
-61.90%3.77M
-23.35%5.60M
-28.69%7.73M
-46.68%7.21M
-41.75%9.90M
-62.41%7.31M
-50.57%10.84M
-46.42%13.53M
-41.05%17.00M
-38.05%19.45M
68.49%21.93M
63.37%25.25M
62.66%28.84M
Net operating income
-213.96%-4.00M
-51.64%-2.08M
-6.76%-2.08M
-42.94%-2.54M
36.60%-1.27M
42.15%-1.37M
32.66%-1.95M
35.87%-1.78M
25.74%-2.01M
12.38%-2.37M
17.75%-2.90M
-14.08%-2.77M
21.94%-2.71M
-9.47%-2.71M
-13.78%-3.53M
25.38%-2.43M
-6.22%-3.47M
5.79%-2.47M
-57.23%-3.10M
-60.19%-3.25M
Net investment
250.00%3.00K
-100.00%0.00
---7.00K
---3.00K
---2.00K
--8.00K
--0.00
----
----
--0.00
100.00%0.00
50.00%-5.00K
100.00%0.00
--0.00
76.67%-7.00K
33.33%-10.00K
-1633.33%-104.00K
100.00%0.00
-275.00%-30.00K
---15.00K
Net financing
-100.00%0.00
815.50%12.40M
-23.55%2.02M
--40.00K
229425.00%9.17M
-43.61%1.35M
--2.65M
-100.00%0.00
89.47%-4.00K
120050.00%2.40M
100.00%0.00
--5.05M
-52.00%-38.00K
300.00%2.00K
-101.29%-3.00K
--0.00
-100.12%-25.00K
---1.00K
1470.59%233.00K
-100.00%0.00

FAQs

What are the current assets of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its current assets were 21.48M, with a year-on-year change of 274.41.

What are the total assets of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its total assets of Phio Pharmaceuticals Corp were 21.49M, with a year-on-year change of 274.47.

What are the total liabilities of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its total liabilities of Phio Pharmaceuticals Corp were 1.34M, with a year-on-year change of 32.02.

What is the total equity of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its total equity of Phio Pharmaceuticals Corp was 20.15M, with a year-on-year change of 326.57.

What is the net operating income of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its net operating income of Phio Pharmaceuticals Corp was -9.22M, with a year-on-year change of -24.81.

What is the net investment of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its net investment of Phio Pharmaceuticals Corp was -12.00K, with a year-on-year change of -250.00.

What is the net financing of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its net financing of Phio Pharmaceuticals Corp was 23.64M, with a year-on-year change of 491.59.

What is the Earnings Per Share (EPS) of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -1.45, with a year-on-year change of 83.99.

What is the net income of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its net income was -8.70M, with a year-on-year change of -21.65.

What is the Return on Equity (ROE) of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its Return on Equity (ROE) was -69.95, with a year-on-year change of 39.09.

What is the Return on Assets (ROA) of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its Return on Assets (ROA) was -63.90, with a year-on-year change of 32.52.

What is the operating profit of Phio Pharmaceuticals Corp?

According to Phio Pharmaceuticals Corp's FY2025 earnings report, its operating profit was -9.22M, with a year-on-year change of -24.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.